dr. tykodi on the efficacy of dual checkpoint blockade in rcc
Published 4 years ago • 59 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
2:25
dr. tykodi on the keynote-427 trial with pembrolizumab in rcc
-
11:30
immune checkpoint inhibitors in combination therapy for rcc
-
8:27
checkpoint inhibition in renal cell carcinoma
-
10:32
managing checkpoint inhibitor therapy in renal cell carcinoma
-
11:46
immune checkpoint inhibitors in renal cell carcinoma
-
6:44
immune checkpoint inhibition in renal cell carcinoma
-
6:07
sequential use of immune checkpoint inhibitors in renal cell carcinoma
-
6:25
contextualizing new data on checkpoint inhibitors for non-clear cell rcc
-
3:26
understanding your kidney cancer diagnosis
-
14:37
ct of calyceal abnormalities in the kidney: pearls and pitfalls - part 1
-
16:53
transitional cell carcinoma of the kidneys 2022: pearls and pitfalls - part 2
-
0:49
immune checkpoint inhibition could be the future of renal cell carcinoma treatment
-
5:34
nephrectomy after complete response to immune checkpoint inhibitors for mrcc
-
38:59
new and emerging systemic treatment options for metastatic kidney cancer scott s. tykodi, m.d., phd.
-
52:18
immune checkpoint inhibitors and rcc: where are we now?
-
1:54
dr. figlin on tki therapy options in renal cell carcinoma
-
4:34
pd-1 inhibition in renal cell carcinoma
-
35:00
t cell checkpoint inhibitors in rcc: a new hope? david f. mcdermott, m.d.
-
6:38
rcc: following patients on immunotherapy vs tki therapy
-
1:24:27
the renal pathology of check point inhibitors
-
3:05
focus on kidney: carmena and renal cell carcinoma
-
2:14
treatment options for kidney cancer from dr. scott tykodi